We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Global life sciences search specialist Coulter Partners has added Nicolaj Moerk Thomsen as senior consultant and Lisbeth Holm as research associate in the firm’s new Copenhagen offices. Mr. Thomsen has 14 years’ experience in global executive search within life sciences. From highly scientific to strictly commercial roles, he has developed a broad expertise across a range of early start-up
Global Life Sciences search specialist Coulter Partners has added Emma Hiom as principal and Zubair Yusuf as senior associate in the U.K. “We are delighted to attract such versatile talent to consolidate the research team in this strong growth phase at Coulter Partners,” said Sharon Shields, managing director. Ms. Hiom joins the firm after having been director of her
Search firm Coulter Partners has named Shawn O’Connor as managing director of its U.S. business and head of the firm’s newly opened office in Morristown, NJ. With 25 years of experience in the life sciences industry, he brings a unique perspective, focusing on senior executive and direct report-level assignments within the life sciences sector. With extensive experience in leading and driving business
LONDON, UK, April 21, 2017 – Coulter Partners was delighted to work with Bluebee, a leading provider of high performance genomics solutions, to secure the appointment of two new members to its Board of Directors. Lars Kongbak has been appointed as an independent director, and Nicolas Roelofs will become Chairman of the Board. Bluebee (www.bluebee.com) provides
LONDON, UK, March 15, 2017 – Coulter Partners was delighted to partner with Poxel SA to secure the appointment of Christophe Arbet-Engels, MD, PhD, MBA, as Chief Medical Officer and EVP Late Development & Medical Affairs, based in Boston. POXEL SA (Euronext – POXEL – FR0012432516) is an international biopharmaceutical company focused on the development of
LONDON, U.K., February 9, 2017 – Coulter Partners was delighted to partner with international biotechnology company, Oxford BioTherapeutics, to secure the appointments of Bernd Seizinger M.D., Ph.D. as Chairman and Jean- Pierre Bizzari, M.D. as non-executive director to the Board of Directors. A clinical-stage biotechnology company developing antibody therapeutics for cancer, Oxford BioTherapeutics has a
LONDON, U.K., January 26, 2017 — Coulter Partners was delighted to partner with Kymab to secure the appointment of Dr Arndt Schottelius as its first Executive Vice President Research & Development. Kymab Group Limited is a leading biopharmaceutical group focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary Kymouse™ antibody platform. Dr
LONDON, U.K., January 25, 2017 — Coulter Partners was delighted to partner withleon-nanodrugs GmbH to secure the appointment of pharma expert Michael Mehler, Sc.D. as new CEO of the Munich based company and its U.S. subsidiary leon-nanodrugs Inc. He succeeds Dr. Theron Odlaug who will continue to serve the company on the Supervisory Board. leon-nanodrugs GmbH, headquartered in Munich,
News
Top hires for Q3-2025
Top hires for Q2-2025
Coulter Partners: Fostering Digital Health connections on the Seine
Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership
Coulter Partners joins key discussion on HealthTech Boards at NHS Innovation Accelerator day
Coulter Partners at the BIA Life Science Leadership Summit: Fostering Board Excellence and UK Biotech Growth!
Coulter Partners attends LabCentral’s Luminescence: Rise & Fund event in Boston, MA
Leadership in MedTech: Key insights from our Paris roundtable
Coulter Partners co-hosts premier UK HealthTech Super Connector event
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024